James A Cochran insider trades: Greenway Medical Technologies (GWAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 21, 2013 | GWAY | ↓ Sell | 10,000 | $15.30 | $153K | Direct | Feb 25, 2013 (4d) |
| Nov 29, 2012 | GWAY | ↓ Sell | 10,000 | $19.39 | $194K | Direct | Nov 30, 2012 (1d) |
| Nov 6, 2012 | GWAY | ↓ Sell | 15,000 | $16.52 | $248K | Direct | Nov 8, 2012 (2d) |
| Jan 27, 2010 | DLA | ↓ Sell | 5,500 | $12.51 | $69K | Direct | Jan 28, 2010 (1d) |
| Feb 3, 2009 | DLA | ↑ Buy | 5,000 | $4.08 | $20K | Direct | Feb 4, 2009 (1d) |
| Mar 10, 2008 | OVEN | ↓ Sell | 760 | $6.87 | $5K | Direct | Mar 11, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James A Cochran's insider trades
James A Cochran is Chief Financial Officer at Greenway Medical Technologies (GWAY). Since Mar 10, 2008, James has reported 1 open-market purchase worth $20K and 5 sales worth $669K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (12 filings), grants and awards (10 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GWAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.